| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
657 |
488 |
$707K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,267 |
1,755 |
$375K |
| 92134 |
|
4,652 |
3,754 |
$92K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,308 |
2,656 |
$88K |
| J9035 |
Injection, bevacizumab, 10 mg |
356 |
234 |
$43K |
| 92226 |
|
1,028 |
645 |
$24K |
| 92202 |
|
2,414 |
2,055 |
$14K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
155 |
124 |
$3K |
| 92225 |
|
84 |
44 |
$3K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,728 |
1,178 |
$0.20 |
| 2022F |
|
450 |
296 |
$0.08 |
| 4040F |
|
1,533 |
1,026 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
745 |
485 |
$0.00 |
| 5010F |
|
254 |
155 |
$0.00 |
| 2021F |
|
255 |
156 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
25 |
13 |
$0.00 |
| 1036F |
|
1,388 |
953 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
545 |
336 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
254 |
155 |
$0.00 |